Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus

Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus

This study aimed to indicate whether autologous bone marrow cell infusion (ABMI) via the right omental vein (ROV) could have a regulatory effect on decompensated liver cirrhosis (DLC) patients with type 2 diabetes mellitus (T2DM). For this purpose, 24 DLC patients with T2DM were divided into observa...

Full description

Saved in:
Bibliographic Details
Main Authors: Baochi Liu, Mingrong Cheng, Lin Lang, Lei Li, Yanhui Si, Guangmian Wang
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
autologous bone marrow infusion
decompensated cirrhosis
type 2 diabetes
cell therapy
surgery-related complications
Physiology
QP1-981
Online Access:https://doaj.org/article/058bde326aaf4c05a60d97ed690c01eb
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/058bde326aaf4c05a60d97ed690c01eb

Similar Items